Susvimo 100 mg/mL injection Images

Generic Name: ranibizumab

This medication has been identified as Susvimo 100 mg/mL injection. It is supplied by Genentech, Inc.

Susvimo is used in the treatment of Macular Degeneration; Diabetic Retinopathy; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Susvimo 100 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Susvimo

Generic Name

ranibizumab

Strength

100 mg/mL injection

Availability

Prescription only

Drug Class

Anti-angiogenic ophthalmic agents

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0078

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer